APO Research
Talk to an analyst

APO RESEARCH · REPORT

Substance P

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Substance P Market Outlook and Growth Opportunities 2026

30 December 2025197 pages

Choose your research edition.

Industry ResearchSubstance P Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Substance P Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Substance P Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Substance P Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Substance P Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Substance P market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Substance P market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Substance P market include Tocris Bioscience, R and D Systems, Peptide Institute, Genscript and BioCrick, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Substance P market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Substance P and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Substance P sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Substance P market size, projected growth trends, production technologies, key applications, and end-use industries.

Substance P Segment by Company

Tocris Bioscience

R and D Systems

Peptide Institute

Genscript

BioCrick

Substance P Segment by Type

Rat

Bovine

Human

Mouse

Substance P Segment by Application

Scientific Research

Medical

Others

Substance P Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Substance P status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Substance P market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Substance P significant trends, drivers, influence factors in global and regions.

6. To analyze Substance P competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Substance P market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Substance P and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Substance P.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Substance P market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Substance P industry.

Chapter 3: Detailed analysis of Substance P manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Substance P in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Substance P in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Substance P Industry Trends Table 2. Substance P Industry Drivers Table 3. Substance P Industry Opportunities and Challenges Table 4. Substance P Industry Restraints Table 5. Global Substance P Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Substance P Revenue Share by Company (2021-2026) Table 7. Global Substance P Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Substance P Sales Volume Share by Company (2021-2026) Table 9. Global Substance P Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Substance P Company Ranking, (2024-2026) & (USD Million) Table 11. Global Substance P Key Company Manufacturing Base & Headquarters Table 12. Global Substance P Company, Product Type & Application Table 13. Global Substance P Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Substance P by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rat Table 18. Significant Companies of Bovine Table 19. Significant Companies of Human Table 20. Significant Companies of Mouse Table 21. Global Substance P Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Substance P Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Substance P Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Substance P Sales Volume Share by Type (2021-2026) Table 25. Global Substance P Sales Volume Share by Type (2027-2032) Table 26. Global Substance P Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Substance P Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Substance P Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Substance P Sales Value Share by Type (2021-2026) Table 30. Global Substance P Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Scientific Research Table 32. Significant Companies of Medical Table 33. Significant Companies of Others Table 34. Global Substance P Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Substance P Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Substance P Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Substance P Sales Volume Share by Application (2021-2026) Table 38. Global Substance P Sales Volume Share by Application (2027-2032) Table 39. Global Substance P Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Substance P Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Substance P Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Substance P Sales Value Share by Application (2021-2026) Table 43. Global Substance P Sales Value Share by Application (2027-2032) Table 44. Global Substance P Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Substance P Sales by Region (2021-2026) & (K Units) Table 46. Global Substance P Sales Market Share by Region (2021-2026) Table 47. Global Substance P Sales by Region (2027-2032) & (K Units) Table 48. Global Substance P Sales Market Share by Region (2027-2032) Table 49. Global Substance P Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Substance P Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Substance P Sales Value Share by Region (2021-2026) Table 52. Global Substance P Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Substance P Sales Value Share by Region (2027-2032) Table 54. Global Substance P Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Substance P Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Substance P Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Substance P Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Substance P Sales by Country (2021-2026) & (K Units) Table 59. Global Substance P Sales Market Share by Country (2021-2026) Table 60. Global Substance P Sales by Country (2027-2032) & (K Units) Table 61. Global Substance P Sales Market Share by Country (2027-2032) Table 62. Global Substance P Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Substance P Sales Value Market Share by Country (2021-2026) Table 64. Global Substance P Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Substance P Sales Value Market Share by Country (2027-2032) Table 66. Tocris Bioscience Company Information Table 67. Tocris Bioscience Business Overview Table 68. Tocris Bioscience Substance P Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Tocris Bioscience Substance P Product Portfolio Table 70. Tocris Bioscience Recent Development Table 71. R and D Systems Company Information Table 72. R and D Systems Business Overview Table 73. R and D Systems Substance P Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. R and D Systems Substance P Product Portfolio Table 75. R and D Systems Recent Development Table 76. Peptide Institute Company Information Table 77. Peptide Institute Business Overview Table 78. Peptide Institute Substance P Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Peptide Institute Substance P Product Portfolio Table 80. Peptide Institute Recent Development Table 81. Genscript Company Information Table 82. Genscript Business Overview Table 83. Genscript Substance P Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Genscript Substance P Product Portfolio Table 85. Genscript Recent Development Table 86. BioCrick Company Information Table 87. BioCrick Business Overview Table 88. BioCrick Substance P Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. BioCrick Substance P Product Portfolio Table 90. BioCrick Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Substance P Distributors List Table 94. Substance P Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Substance P Product Image Figure 2. Global Substance P Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Substance P Sales Value (2021-2032) & (US$ Million) Figure 4. Global Substance P Sales (2021-2032) & (K Units) Figure 5. Global Substance P Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Substance P Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rat Image Figure 10. Bovine Image Figure 11. Human Image Figure 12. Mouse Image Figure 13. Global Substance P Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Substance P Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Substance P Sales Volume Share by Type (2021-2032) Figure 16. Global Substance P Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Substance P Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Substance P Sales Value Share by Type (2021-2032) Figure 19. Scientific Research Image Figure 20. Medical Image Figure 21. Others Image Figure 22. Global Substance P Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Substance P Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Substance P Sales Volume Share by Application (2021-2032) Figure 25. Global Substance P Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Substance P Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Substance P Sales Value Share by Application (2021-2032) Figure 28. Global Substance P Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Substance P Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Substance P Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Substance P Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Substance P Sales Value (2021-2032) & (US$ Million) Figure 33. North America Substance P Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Substance P Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Substance P Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Substance P Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Substance P Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Substance P Sales Value (2021-2032) & (US$ Million) Figure 39. South America Substance P Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Substance P Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Substance P Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Substance P Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Substance P Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Substance P Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Substance P Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Substance P Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Rat
  • Bovine
  • Human
  • Mouse
Applications
  • Scientific Research
  • Medical
  • Others
Companies covered
  • Tocris Bioscience
  • R and D Systems
  • Peptide Institute
  • Genscript
  • BioCrick

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Substance P Sales Value (2021-2032)
  4. 1.2.2 Global Substance P Sales Volume (2021-2032)
  5. 1.2.3 Global Substance P Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Substance P Market Dynamics
  1. 2.1 Substance P Industry Trends
  2. 2.2 Substance P Industry Drivers
  3. 2.3 Substance P Industry Opportunities and Challenges
  4. 2.4 Substance P Industry Restraints
3 Substance P Market by Company
  1. 3.1 Global Substance P Company Revenue Ranking in 2025
  2. 3.2 Global Substance P Revenue by Company (2021-2026)
  3. 3.3 Global Substance P Sales Volume by Company (2021-2026)
  4. 3.4 Global Substance P Average Price by Company (2021-2026)
  5. 3.5 Global Substance P Company Ranking (2024-2026)
  6. 3.6 Global Substance P Company Manufacturing Base and Headquarters
  7. 3.7 Global Substance P Company Product Type and Application
  8. 3.8 Global Substance P Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Substance P Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Substance P Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Substance P Market by Type
  1. 4.1 Substance P Type Introduction
  2. 4.1.1 Rat
  3. 4.1.2 Bovine
  4. 4.1.3 Human
  5. 4.1.4 Mouse
  6. 4.2 Global Substance P Sales Volume by Type
  7. 4.2.1 Global Substance P Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Substance P Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Substance P Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Substance P Sales Value by Type
  11. 4.3.1 Global Substance P Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Substance P Sales Value by Type (2021-2032)
  13. 4.3.3 Global Substance P Sales Value Share by Type (2021-2032)
5 Substance P Market by Application
  1. 5.1 Substance P Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Substance P Sales Volume by Application
  6. 5.2.1 Global Substance P Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Substance P Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Substance P Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Substance P Sales Value by Application
  10. 5.3.1 Global Substance P Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Substance P Sales Value by Application (2021-2032)
  12. 5.3.3 Global Substance P Sales Value Share by Application (2021-2032)
6 Substance P Regional Sales and Value Analysis
  1. 6.1 Global Substance P Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Substance P Sales by Region (2021-2032)
  3. 6.2.1 Global Substance P Sales by Region: 2021-2026
  4. 6.2.2 Global Substance P Sales by Region (2027-2032)
  5. 6.3 Global Substance P Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Substance P Sales Value by Region (2021-2032)
  7. 6.4.1 Global Substance P Sales Value by Region: 2021-2026
  8. 6.4.2 Global Substance P Sales Value by Region (2027-2032)
  9. 6.5 Global Substance P Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Substance P Sales Value (2021-2032)
  12. 6.6.2 North America Substance P Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Substance P Sales Value (2021-2032)
  15. 6.7.2 Europe Substance P Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Substance P Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Substance P Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Substance P Sales Value (2021-2032)
  21. 6.9.2 South America Substance P Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Substance P Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Substance P Sales Value Share by Country, 2025 VS 2032
7 Substance P Country-level Sales and Value Analysis
  1. 7.1 Global Substance P Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Substance P Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Substance P Sales by Country (2021-2032)
  4. 7.3.1 Global Substance P Sales by Country (2021-2026)
  5. 7.3.2 Global Substance P Sales by Country (2027-2032)
  6. 7.4 Global Substance P Sales Value by Country (2021-2032)
  7. 7.4.1 Global Substance P Sales Value by Country (2021-2026)
  8. 7.4.2 Global Substance P Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Substance P Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Substance P Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Substance P Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Substance P Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Substance P Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Substance P Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Substance P Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Substance P Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Substance P Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Substance P Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Substance P Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Substance P Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Substance P Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Substance P Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Substance P Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Substance P Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Substance P Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Substance P Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Substance P Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Substance P Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Substance P Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Substance P Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Substance P Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Substance P Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Substance P Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Substance P Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Substance P Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Substance P Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Substance P Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Substance P Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Substance P Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Substance P Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Substance P Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Substance P Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Substance P Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Substance P Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Substance P Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Substance P Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Substance P Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Substance P Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Substance P Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Substance P Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Substance P Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Substance P Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Substance P Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Substance P Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Substance P Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Substance P Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Substance P Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Substance P Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Substance P Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Substance P Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Substance P Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Substance P Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Substance P Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Substance P Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Substance P Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Substance P Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Substance P Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Substance P Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Substance P Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Substance P Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Substance P Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Substance P Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Substance P Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Substance P Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Substance P Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Substance P Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Substance P Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Substance P Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Substance P Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Substance P Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Substance P Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Substance P Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Substance P Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Substance P Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Substance P Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Substance P Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Substance P Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Substance P Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Substance P Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Substance P Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Substance P Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Substance P Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tocris Bioscience
  2. 8.1.1 Tocris Bioscience Company Information
  3. 8.1.2 Tocris Bioscience Business Overview
  4. 8.1.3 Tocris Bioscience Substance P Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tocris Bioscience Substance P Product Portfolio
  6. 8.1.5 Tocris Bioscience Recent Developments
  7. 8.2 R and D Systems
  8. 8.2.1 R and D Systems Company Information
  9. 8.2.2 R and D Systems Business Overview
  10. 8.2.3 R and D Systems Substance P Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 R and D Systems Substance P Product Portfolio
  12. 8.2.5 R and D Systems Recent Developments
  13. 8.3 Peptide Institute
  14. 8.3.1 Peptide Institute Company Information
  15. 8.3.2 Peptide Institute Business Overview
  16. 8.3.3 Peptide Institute Substance P Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Peptide Institute Substance P Product Portfolio
  18. 8.3.5 Peptide Institute Recent Developments
  19. 8.4 Genscript
  20. 8.4.1 Genscript Company Information
  21. 8.4.2 Genscript Business Overview
  22. 8.4.3 Genscript Substance P Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Genscript Substance P Product Portfolio
  24. 8.4.5 Genscript Recent Developments
  25. 8.5 BioCrick
  26. 8.5.1 BioCrick Company Information
  27. 8.5.2 BioCrick Business Overview
  28. 8.5.3 BioCrick Substance P Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BioCrick Substance P Product Portfolio
  30. 8.5.5 BioCrick Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Substance P Value Chain Analysis
  2. 9.1.1 Substance P Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Substance P Sales Mode & Process
  6. 9.2 Substance P Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Substance P Distributors
  9. 9.2.3 Substance P Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst